Are "Zombie Cells" Really Villains? — The Surprising Answer from Longevity Research

In the world of aging research, there has long been an entity considered an "enemy to be vanquished."
This entity is the senescent cell, commonly referred to as the "zombie cell."

The name "zombie cell" sounds ominous. They are not dead, yet they do not actively divide like young cells. They linger in the body, spreading inflammatory substances around them, gradually degrading tissue function. This has been the prevailing image of senescent cells.

Indeed, senescent cells accumulate in the body with age and are thought to be related to various age-related diseases such as diabetes, arteriosclerosis, cognitive decline, fibrosis of the lungs and liver, and cancer progression. Therefore, recent anti-aging research has heightened expectations for drugs that remove senescent cells, known as senolytics.

However, the latest review research challenges this simplistic view.

Not all senescent cells are villains.
On the contrary, some senescent cells may play crucial roles in aiding wound repair, maintaining tissue balance, and contributing to development and regeneration.

In other words, the issue is not whether to eliminate zombie cells or not.
The focus is shifting to which zombie cells should be eliminated and which should be preserved.

What Are Senescent Cells?

Senescent cells are cells that have permanently ceased to divide.
Cells endure various stresses such as DNA damage, oxidative stress, telomere shortening, mitochondrial dysfunction, chronic inflammation, ultraviolet rays, and pollutants. In response, they may stop dividing as a safety mechanism to prevent cancer.

This mechanism is originally intended to protect the body.
If damaged cells proliferate unchecked, there is a risk of cancer. The braking mechanism that stops cells from further division is a necessary defense reaction for maintaining life.

However, the problem arises afterward.

Even when senescent cells stop dividing, they do not become completely silent. In many cases, they secrete various signaling substances into their surroundings. This collection of secretions is called SASP, which includes inflammatory cytokines, growth factors, and enzymes that decompose and reconstruct tissue.

In the short term, these signals help in wound repair and attracting immune cells.
However, if senescent cells persist too long, they can cause chronic inflammation, involve surrounding healthy cells, and tilt the entire tissue towards aging.

This duality is what makes senescent cell research challenging.

Is "Eliminating Them All Will Rejuvenate Us" True?

Could removing senescent cells slow down aging?
This idea has significantly influenced aging research over the past decade or so.

Senolytics, a group of drugs, aim to selectively kill senescent cells by blocking the pathways they use to survive. Common candidates include dasatinib, quercetin, and fisetin. In animal experiments, the removal of senescent cells has shown improvements in physical function and reductions in age-related diseases.

As a result, the straightforward message "kill zombie cells to rejuvenate" has easily spread in articles and on social media.

However, the review highlighted in this discussion offers a more cautious revision of this perspective.

Senescent cells are not a uniform group.
Their characteristics vary depending on the organs they are in, such as the liver, lungs, kidneys, heart, adipose tissue, brain, and skin. Moreover, even within the same organ, the type of senescent cells, the surrounding microenvironment, and the causes leading to senescence can significantly alter their functions.

Some senescent cells exacerbate inflammation.
Other senescent cells aid in wound repair.
Yet other senescent cells might act as brakes to suppress fibrosis.

Considering this, indiscriminately eradicating senescent cells is not necessarily safe. It could disrupt the body's inherent repair functions, immune surveillance, vascular stability, and tissue structure maintenance.

Especially in vital organs like the heart, lungs, and brain, even minor side effects could pose significant problems.

The Different Faces of Senescent Cells in the Liver, Lungs, and Brain

The review organizes the roles of senescent cells in various organs.

For example, in the liver, senescent endothelial and immune cells might promote inflammation and fibrosis, potentially impairing lipid metabolism and regenerative capacity. On the other hand, the senescence of hepatic stellate cells may act as a brake on excessive fibrosis. Thus, even within the same liver, there is a mix of "deteriorating senescence" and "suppressive senescence."

In the lungs, pollutants, smoking, particulates, and oxidative stress contribute to the accumulation of senescent cells. Senescent alveolar epithelial cells and endothelial cells are thought to underlie chronic obstructive pulmonary disease and pulmonary fibrosis. However, the senescence of lung fibroblasts may serve to halt excessive scar formation.

In the brain, senescent glial cells are suggested to be involved in neuroinflammation and cognitive decline. However, in organs like the brain, which have limited regenerative capacity, it is not yet fully understood what long-term effects the indiscriminate removal of senescent cells might have.

Faced with such complexity, the simple label "senescent cells = bad" does not hold.

The New Keyword is "Precision Senescence Defense"

A significant concept introduced in this study is an approach that can be translated as "precision senescence defense."

This approach does not attack senescent cells wholesale but seeks to identify and eliminate only the harmful senescent cells driving disease, while preserving necessary cells.

This idea is similar to precision medicine in cancer treatment.
In the past, the primary goal was to "attack cancer cells." However, now the focus has shifted to selecting treatments for each patient based on genetic mutations, immune environments, and drug sensitivities.

Senescent cell research is attempting to follow the same path.

To achieve this, technologies such as single-cell omics, lineage tracing, and spatial analysis are necessary. These can be used to investigate where senescent cells are located within tissues, what types they are, and how they change over time.

It is insufficient to determine "whether a cell is senescent" based solely on markers like p16 or SA-β-gal.
From now on, we must look at "what those senescent cells are doing."

Are they causing inflammation?
Are they aiding in repair?
Are they promoting cancer progression?
Are they stopping fibrosis?
Should they be eliminated by immune cells, or should they temporarily remain?

The era of distinguishing senescent cells by "function" rather than "state" is upon us.

From Senolytics to Senomorphics

There are two main directions in treatments targeting senescent cells.

One is senolytics, which aim to kill senescent cells.
The other is senomorphics, which do not kill senescent cells but suppress their harmful secretory signals.

Senomorphics aim to weaken the SASP that causes chronic inflammation without removing the senescent cells themselves. If it is possible to suppress only the harmful inflammation while preserving functions necessary for repair, it could lead to safer interventions.

Furthermore, research is progressing on applying immunotherapy, such as CAR-T cells, to recognize and eliminate specific markers on the surface of senescent cells. This is a trend of applying technologies developed in cancer immunotherapy to aging research.

However, these treatments are still in development and are not at a stage where they can be used by the general public on their own judgment. Particularly, caution is needed when using components distributed as anticancer drugs or supplements as "senescent cell countermeasures."

Aging is not a single disease but a change in the entire body's network.
It is not as simple as solving the problem by manipulating a single cell or substance.

On Social Media, "Expectations" and "Caution" Spread Simultaneously

 

This topic has also generated some reactions on social media.

However, rather than an explosive buzz, it seems to be quietly shared among those interested in aging research, biotech, healthy lifespan, and future medicine.

In Reddit's aging-related community, while the ScienceDaily article was posted, it had not yet sparked a large comment exchange at the time of checking. Meanwhile, related themes such as "drugs to remove zombie cells," "can aging be treated," and "who are rejuvenation drugs for" were lined up, indicating that senescent cells remain a topic of ongoing interest in the longevity community.

On LinkedIn, users interested in biotech and medical research focused on the necessity of "selective adjustment" rather than completely eliminating senescent cells. Posts highlighted the view of preserving the roles of senescent cells involved in wound healing, tissue remodeling, and tumor suppression while suppressing harmful aspects related to chronic inflammation.

On platforms like Bluesky and Instagram, accounts like Aging-US and related ones have been sharing papers, illustrations, and short videos, with the spread leaning towards researchers and science communication. Hashtags such as aging, longevity, and anti-aging are used, presenting it as a topic with expertise.

Interestingly, the reception on social media tends to split into two.

On one hand, there is the expectation that "rejuvenation medicine has taken another step forward" and "aging might become a treatable target."
On the other hand, there is caution, with concerns like "will it become a technology only for the wealthy to extend their lifespan," "is it safe to forcibly manipulate aging," and "is it appropriate to directly apply discussions at the mouse or review stage to humans."

In past Reddit posts, discussions about drugs to remove zombie cells included skepticism about whether it would become a technology for the rich to live longer and doubts about the safety of removing senescent cells.

This study provides a somewhat calm answer to both these expectations and cautions.

There is potential in controlling senescent cells.
However, it is not simply about eradicating them indiscriminately.
And there are still many challenges remaining for clinical application.

The Future of Anti-Aging is Shifting from "Rejuvenation" to "Healthy Lifespan"

Generally, the term anti-aging is often associated with a youthful appearance and extended lifespan. However, in the research field, the focus is more on extending the period of healthy living, or healthy lifespan, rather than merely living longer.

Senescent cell research is also moving in that direction.

By suppressing harmful senescent cells, reducing chronic inflammation, delaying the decline of organ function, and preventing the onset and progression of age-related diseases, it could significantly improve the quality of life in old age if realized.

However, there are at least three barriers to achieving this.

First, there is a lack of biomarkers to accurately distinguish senescent cells.
Without being able to discern which cells are harmful and which are beneficial, precise treatment is impossible.

Second, technology is needed to deliver drugs to the correct location.
If drugs administered throughout the body act on organs other than the target, the risk of side effects increases.

Third, the long-term effects are unknown.
It is not yet fully understood what impact temporarily reducing senescent cells will have on tissue repair and immune function years or decades later.

Therefore, the idea emphasized in this review of "prevention first, precise intervention" is important.

Instead of forcibly removing cells after aging has progressed, it is essential to suppress the causes of increased senescent cells as much as possible, such as oxidative stress, metabolic abnormalities, chronic inflammation, and environmental stress. And for already accumulated senescent cells, interventions should be minimal and based on their functions.

This is not a flashy story of rejuvenation.
Rather, it is closer to medicine that "manages" aging.

What the Word "Zombie" Conceals

The term "zombie cell" is easy to understand.
However, simplicity can sometimes lead to misunderstandings.

When people hear "zombie," they often imagine something that should be defeated.
But senescent cells in the body are not monsters from a horror movie. They are born to protect the body, support repair when needed, and are involved in inflammation and disease when conditions worsen. In other words, they can be allies or enemies depending on the context.

Life is not black and white; it is based on balance.

The same goes for inflammation.
Short-term inflammation is necessary for infection defense and wound repair, but if it becomes chronic, it can cause disease.

The same goes for the cessation of cell division.
It is necessary to prevent cancer, but if it accumulates too much, it accelerates tissue aging.

The same applies to senescent cells.
There is necessary senescence and harmful senescence.

What this study suggests is the need to understand aging not merely as deterioration but as a biological system that changes over time. Senescent cells are at the center of this. However, they are not solitary culprits but part of a complex network.

The Perspective Needed for Future Longevity Research

The message we should take from this study is not the simplistic notion that "zombie cells are the secret to longevity."

More accurately, it is this.

Among senescent cells, some are detrimental to health, while others are beneficial for maintaining health. Therefore, in future anti-aging medicine, it is necessary to handle senescent